Stocktoria
MAIA Biotechnology, Inc. MAIA
NYSE American · XASE · stock · Pharmaceutical Preparations · website · IPO 2022-07-28
MAIA Biotechnology, Inc. statistics & valuation
Market cap$90.0M
P / B37.9×
Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -230.8% | -229.0% | — | — | — |
| Return on equity | -942.7% | -639.8% | — | — | — |
| Current ratio | 1.66 | 2.65 | 1.53 | 3.61 | 4.97 |
Source: SEC EDGAR filings · CIK 0001878313 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.